Rita Keynan
Corporate Officer/Principal bei PAINREFORM LTD.
Profil
Rita Keynan is currently the Vice President-Pharmaceutical Operations at PainReform Ltd.
Her former job was as the Executive Director-Drug Development at VYNE Pharmaceuticals Ltd.
She received her undergraduate and graduate degrees from The Hebrew University of Jerusalem.
Aktive Positionen von Rita Keynan
| Unternehmen | Position | Beginn |
|---|---|---|
| PAINREFORM LTD. | Corporate Officer/Principal | 06.01.2021 |
Ehemalige bekannte Positionen von Rita Keynan
| Unternehmen | Position | Ende |
|---|---|---|
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Corporate Officer/Principal | - |
Ausbildung von Rita Keynan
| The Hebrew University of Jerusalem | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PAINREFORM LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |